About Souzhou Ribo Life Science
Souzhou Ribo Life Science is a company based in Suzhou (China) founded in 2007 by Zicai Liang.. Souzhou Ribo Life Science has raised $200.79 million across 6 funding rounds from investors including CICC, Panlin Capital and Sany Innovation Fund. Souzhou Ribo Life Science operates in a competitive market with competitors including Jazz Pharmaceuticals, Horizon Discovery, C4 Therapeutics, Erasca and Revolution Medicines, among others.
- Headquarter Suzhou, China
- Founders Zicai Liang
- Stage Public
-
Sectors
HealthcareTechnology
-
Email
***********
-
Phone
*********
-
Website
*********
-
Social
*********
- Legal Name Suzhou Ribo Life Science Co., Ltd. Class H
-
Annual Revenue
-
Net Profit
-
EBITDA
-
Total Equity Funding
$200.79 M (USD)
in 6 rounds
-
Latest Funding Round
$40 M (USD), Series E
Jul 29, 2022
-
Investors
CICC
& 14 more
-
Employee Count
Employee Count
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
IPO & Listings of Souzhou Ribo Life Science
Souzhou Ribo Life Science is a publicly listed company on the HKEX with ticker symbol 6938 in Hong Kong, operating in the Health technology sector. As a publicly traded entity, the company provides investors with opportunities to participate in its growth story through equity ownership. The listing enables access to capital markets, enhances corporate visibility, and provides liquidity for shareholders while maintaining transparency through regulatory compliance and regular financial disclosures.
Funding Insights of Souzhou Ribo Life Science
Souzhou Ribo Life Science has successfully raised a total of $200.79M across 6 strategic funding rounds. The most recent funding activity was a Series E round of $40 million completed in July 2022. This substantial capital infusion reflects strong investor confidence in the company's business model, growth potential, and market opportunities. The funding enables strategic expansion, product development, market penetration, and operational scaling to drive long-term value creation and competitive advantage.
- Total Funding Total Funding
- Total Rounds 6
- Last Round Series E — $40.0M
-
First Round
First Round
(07 Jan 2014)
- Investors Count 15
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2022 | Amount | Series E - Souzhou Ribo Life Science | Valuation | Sany Innovation Fund | |
| Apr, 2020 | Amount | Series C - Souzhou Ribo Life Science | Valuation | CICC , GL Ventures | |
| Dec, 2019 | Amount | Series C - Souzhou Ribo Life Science | Valuation | Panlin Capital |
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Investors in Souzhou Ribo Life Science
Souzhou Ribo Life Science has secured backing from 15 investors, including institutional and venture fund investors. Prominent investors backing the company include CICC, Panlin Capital and Sany Innovation Fund. This diverse investor base provides strategic capital, industry expertise, and valuable network connections that support the company's growth initiatives, market expansion, and long-term value creation.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
-
|
Founded Year | Domain | Location | |
|
Venture capital investments are provided to high-tech enterprises.
|
Founded Year | Domain | Location | |
|
Private equity & venture capital firm
|
Founded Year | Domain | Location |
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Single family office of Amitabh Bachchan, founder of Amitabh Bachchan Corporation or AB CORP
|
Founded Year | Domain | Location | |
|
Startup ecosystems are ignited through strategic investments by Signite Partners.
|
Founded Year | Domain | Location | |
|
Venture capital is directed toward companies in multiple sectors.
|
Founded Year | Domain | Location | |
|
Venture capital is invested in cybersecurity, fintech, and AI startups.
|
Founded Year | Domain | Location |
Investments & Acquisitions by Souzhou Ribo Life Science
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Bionic investment advisor platform
|
2016 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 | ||||
|
Physical e-commerce kiosks are deployed for rural purchases in Indonesia.
|
2014 | ||||
|
Fine Asian gourmet food is offered by an internet-first restaurant.
|
2016 |
Financial Statements - Souzhou Ribo Life Science
| Date | Amount | Transaction Name | Valuation | Lead Investors | Investors |
|---|---|---|---|---|---|
| Jul, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Jan, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
|
| Feb, 2021 | Amount | Post-IPO - Grab | Valuation |
investors |
Souzhou Ribo Life Science Comparisons
Competitors of Souzhou Ribo Life Science
Souzhou Ribo Life Science operates in a dynamic and competitive business environment, facing competition from various established players and emerging companies in the market. The competitive landscape includes prominent companies such as Jazz Pharmaceuticals, Horizon Discovery, C4 Therapeutics, Erasca and Revolution Medicines, among others. This competitive environment drives innovation, market differentiation, and strategic positioning as companies strive to capture market share and deliver value to their customers. Understanding the competitive dynamics is crucial for assessing market positioning, identifying growth opportunities, and navigating the challenges inherent in a competitive marketplace.
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Novel biopharmaceutical medicines are developed for unmet medical needs.
|
|
| domain | founded_year | HQ Location |
Genetically modified cell lines are developed using AAV gene-editing platform.
|
|
| domain | founded_year | HQ Location |
Small-molecule drugs for cancer treatment are developed via Degronimid platform.
|
|
| domain | founded_year | HQ Location |
Small molecule therapeutics for cancer treatment are developed.
|
|
| domain | founded_year | HQ Location |
Cancer therapies are developed using selective pathway inhibitors.
|
|
| domain | founded_year | HQ Location |
MicroRNA-based therapeutics are developed for treating multiple diseases.
|
| Company Name | Domain | Founded year | HQ Location | Description |
|---|---|---|---|---|
| domain | founded_year | HQ Location |
Multiple services are booked via an app-based platform.
|
|
| domain | founded_year | HQ Location |
On-demand services are booked through an app-based platform.
|
|
| domain | founded_year | HQ Location |
App based platform offering on demand delivery and ride-hailing services
|
|
| domain | founded_year | HQ Location |
Operates an on-demand hyperlocal delivery app for food and groceries.
|
Latest news on Souzhou Ribo Life Science
Frequently Asked Questions about Souzhou Ribo Life Science
When was Souzhou Ribo Life Science founded?
Souzhou Ribo Life Science was founded in 2007 and raised its 1st funding round 7 years after it was founded.
Where is Souzhou Ribo Life Science located?
Souzhou Ribo Life Science is headquartered in Suzhou, China. It is registered at Suzhou, Jiangsu, China.
Is Souzhou Ribo Life Science a funded company?
Souzhou Ribo Life Science is a funded company, having raised a total of $200.79M across 6 funding rounds to date. The company's 1st funding round was a Series C of $28.75M, raised on Jan 07, 2014.
What does Souzhou Ribo Life Science do?
Founded in 2007 and based in Suzhou, China, the company operates in the biotechnology sector, specializing in nucleic acid drugs through RNA interference (RNAi) technology. Focus areas include drug discovery, siRNA design and screening, chemical modifications, delivery systems, pharmacokinetic studies, safety evaluations, and clinical trials. Therapeutics targeting Hepatitis B, breast carcinoma, liver fibrosis, liver carcinoma, and HIV are also provided.
Who are the top competitors of Souzhou Ribo Life Science?
Souzhou Ribo Life Science's top competitors include Jazz Pharmaceuticals, Horizon Discovery and C4 Therapeutics.
Is Souzhou Ribo Life Science publicly traded?
Yes, Souzhou Ribo Life Science is publicly traded on HKEX under the ticker symbol 6938.
Who are Souzhou Ribo Life Science's investors?
Souzhou Ribo Life Science has 15 investors. Key investors include CICC, Panlin Capital, Sany Innovation Fund, Langmafeng Venture Capital, and Free Trade Zone Fund.
What is Souzhou Ribo Life Science's ticker symbol?
The ticker symbol of Souzhou Ribo Life Science is 6938 on HKEX.